Episodic Future Thinking and Future Thinking Priming for Smoking Cessation
Promising Methods to Decrease Delay Discounting and Reduce Relapse to Smoking
Sponsor: Roswell Park Cancer Institute
Terminated
low accrual
Other terminated trials from Roswell Park Cancer Institute
- Breast Carcinoma · Apr 2026
- Lung Non-Small Cell Carcinoma · Phase PHASE1 · Jan 2025
- Recurrent Chronic Lymphocytic Leukemia · Phase PHASE1 · Jan 2025
- Platinum-Resistant Fallopian Tube Carcinoma · Phase PHASE1 · Jun 2024
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive · Phase PHASE2 · Aug 2023
This NA trial investigates Tobacco-Related Carcinoma and is currently terminated or withdrawn. Roswell Park Cancer Institute leads this study, which shows 11 recorded versions since 2020 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Mar 2024 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jun 2023 — Mar 2024 [monthly]
Recruiting NA
-
Jun 2022 — Jun 2023 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Oct 2021 — Jun 2022 [monthly]
Recruiting NA
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
-
Sep 2020 — Nov 2020 [monthly]
Recruiting NA
-
Aug 2020 — Sep 2020 [monthly]
Recruiting NA
-
Apr 2020 — Aug 2020 [monthly]
Recruiting NA
First recorded
Jan 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Roswell Park Cancer Institute
For direct contact, visit the study record on ClinicalTrials.gov .